No valuation for Ray Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($106.0M) and the funding record below are the closest available signals.
- ·Watch Ray Therapeutics: the Monday email on marks, rounds and moves
Ray Therapeutics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2023 | Early Stage VC | $14.0M | ▮ | ▮ |
| May 2021 | Early Stage VC | $6.0M | ▮ | ▮ |
Membership and data by Private Market View
How much has Ray Therapeutics raised?
Ray Therapeutics has raised $106 million in total; 2 of its rounds are on record. The largest on record was a $6 million early-stage round in May 2021; the most recent was a $14 million early-stage round in May 2023.
Ray Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in May 2023 ($14 million sold to 13 investors).
How Ray Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ray Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Ray Therapeutics
- How much has Ray Therapeutics raised?
- Ray Therapeutics has raised $106.0M in total funding across 2 recorded rounds.
- When did Ray Therapeutics last raise?
- Ray Therapeutics last raised in May 2023 (Early Stage VC), raising $14.0M.